Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.05.05
北京市中伦状师事务所关于公司首次果真刊行的股票申请在深圳证券生意所上市的执法意见...
2010.05.05
中国建银投资证券有限责任公司关于公司股票上市保荐书
2010.04.29
首次果真刊行股票网上定价刊行摇号中签效果通告
2010.04.28
首次果真刊行股票网下配售效果通告
2010.04.28
首次果真刊行股票网上定价刊行申购情形及中签率通告
2010.04.23
首次果真刊行股票刊行通告
2010.04.23
首次果真刊行股票投资危害特殊通告
2010.04.23
首次果真刊行股票招股说明书摘要
2010.04.23
首次果真刊行股票招股说明书
2010.04.22
首次果真刊行股票网上路演通告
第一页
上一页
147
148
149
150
151
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】